Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Nomogram predicted risk of lymph node metastases in Dutch breast cancer patients
February 2nd, 2006
The Memorial Sloan-Kettering Cancer Center nomogram could be used to predict the risk of nonsentinel lymph node metastases in Dutch breast cancer patients. According to a study from the Netherlands, "According to Dutch guidelines, an axillary lymph node dissection (ALND) is recommended whenever a sentinel lymph node (SLN) contains metastatic disease. However, only in approximately 50% of patients with metastatic disease in the SLN are additional nodal metastases detected in the completion ALND." "To identify the individual patient's risk for non-SLN metastases, a nomogram containing 8 predictors was developed by the Breast Service of Memorial...
Source: Women's Health Weekly (2006-02-02)
|
